Drawing for BRIDAN

USPTO serial 79003883

BRIDAN

Reviewed by CopyMark Law Group

Reg. 2970816Status 404
Filing date
Status date
Registration date
Jul 19, 2005
Examiner
WELLS, CHRISTOPHER
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BRIDAN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Medicines and pharmaceutical preparations for human use, namely, muscle relaxant antagonistsSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 23, 2014DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Oct 23, 2014DETHDEATH OF INTERNATIONAL REGISTRATION—
Nov 9, 2013CHLDCHANGE OF OWNER RECEIVED FROM IB—
Feb 22, 2013NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 1, 2012NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
May 1, 201271AGREGISTERED-SEC.71 ACCEPTED—
May 1, 2012APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 2, 2012CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jan 19, 2012ES71TEAS SECTION 71 RECEIVED—
Sep 7, 2007FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 19, 2007NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 17, 2006FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 16, 2006FIMPFINAL DISPOSITION PROCESSED—
Apr 25, 2006FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 15, 2005ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 15, 2005REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 19, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 26, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 6, 2005NPUBNOTICE OF PUBLICATION—
Feb 8, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 7, 2005ALIEASSIGNED TO LIE—
Jan 31, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 31, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Jan 31, 2005ALIEASSIGNED TO LIE—
Jan 19, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 19, 2005FAXXFAX RECEIVED—
Dec 23, 2004RFNTREFUSAL PROCESSED BY IB—
Nov 19, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 16, 2004CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 25, 2004DOCKASSIGNED TO EXAMINER—
Aug 16, 2004NWAPNEW APPLICATION ENTERED—
Aug 12, 2004REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance